Rapid Reduction in Donor-Specific Anti-Human Leukocyte Antigen Antibodies and Reversal of Antibody-Mediated Rejection With Bortezomib in Pediatric Heart Transplant Patients

BACKGROUND: High titer donor-specific antibodies (DSA) and positive crossmatch in cardiac transplant recipients is associated with increased mortality from antibody-mediated rejection (AMR). Although treatment to reduce antihuman leukocyte antigen antibodies using plasmapheresis, intravenous immunog...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Morrow, William Robert, Frazier, Elizabeth A., Mahle, William T., Harville, Terry O., Pye, Sherry E., Knecht, Kenneth R., Howard, Emily L., Smith, R. Neal, Saylors, Robert L., Garcia, Xiomara, Jaquiss, Robert D.B., Woodle, E. Steve
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2012
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC3730122/
https://ncbi.nlm.nih.gov/pubmed/22179403
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TP.0b013e31823f7eea
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg